CSIMarket Company Name, Ticker, Competitors, else..


Armata Pharmaceuticals Inc   (NYSEAMER: ARMP)
Other Ticker:  
 

Armata Pharmaceuticals Inc

ARMP's Fundamental analysis



Looking into Armata Pharmaceuticals Inc growth rates, revenue grew by 142.69 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1938

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.31 %

Armata Pharmaceuticals Inc net loss decreased from $-31 millions, to $-5 millions in III. Quarter 2024,

• More on ARMP's Growth


Armata Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Armata Pharmaceuticals Inc realized cash reduction of $ -0.2 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.23.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.


• More on ARMP's Valuation
 
 Total Debt (Millions $) 41
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 546,700
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -1.79

Armata Pharmaceuticals Inc
realized net loss in trailing twelve months.

Armata Pharmaceuticals Inc realized cash outflow of $ -0.2per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 14.23.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.


• More on ARMP's Valuation

•  Market Capitalization (Millions $) 78
•  Shares Outstanding (Millions) 36
•  Employees 10
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) -41
•  Cash Flow (TTM) (Millions $) -7
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) 41
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 546,700
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -1.79

•  Market Capitalization (Millions $) 78
•  Shares Outstanding (Millions) 36
•  Employees 10
•  Revenues (TTM) (Millions $) 5
•  Net Income (TTM) (Millions $) -41
•  Cash Flow (TTM) (Millions $) -7
•  Capital Exp. (TTM) (Millions $) -4





  Ratio
•   Capital Ratio (MRQ) 0.19
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.08
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com